These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 33460325)
1. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients. Bodakçi E; Yaşar Bilge NŞ; Ataş N; Armağan B; Satış H; Sarı A; Bilici Salman R; Kübra Yardımcı G; Babaoğlu H; Kılıç L; Öztürk MA; Göker B; Haznedaroğlu Ş; Kalyoncu U; Tufan A; Kaşifoğlu T Turk J Med Sci; 2021 Aug; 51(4):1706-1711. PubMed ID: 33460325 [TBL] [Abstract][Full Text] [Related]
2. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy. Bonfrate L; Scaccianoce G; Palasciano G; Ben-Chetrit E; Portincasa P Eur J Clin Invest; 2017 Sep; 47(9):622-629. PubMed ID: 28678379 [TBL] [Abstract][Full Text] [Related]
3. Familial Mediterranean fever-associated infertility and underlying factors. Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094 [TBL] [Abstract][Full Text] [Related]
4. Frequency of abdominal surgery in patients with familial Mediterranean fever. Kaşifoğlu T; Cansu DU; Korkmaz C Intern Med; 2009; 48(7):523-6. PubMed ID: 19336953 [TBL] [Abstract][Full Text] [Related]
5. Familial Mediterranean fever: perspective on female fertility and disease course in pregnancy from a multicenter nationwide network. Yurdakul FG; Bodur H; Çay HF; Uçar Ü; Keskin Y; Sargın B; Gürer G; Yurdakul OV; Çalış M; Deveci H; Aydın Y; Hizmetli S; Çevik R; Karahan AY; Ataman Ş; Duruöz MT; Ecesoy H; Günendi Z; Toprak M; Şen N; Altıntaş D; Cengiz AK; Çağlayan G; Demir AN; Kaplan H; Ketenci S; Alkan Melikoğlu M; Nayimoğlu M; Nas K; Sarıfakıoğlu B; Sezer İ Rheumatol Int; 2024 Oct; 44(10):2117-2127. PubMed ID: 37658927 [TBL] [Abstract][Full Text] [Related]
6. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Hashkes PJ; Spalding SJ; Giannini EH; Huang B; Johnson A; Park G; Barron KS; Weisman MH; Pashinian N; Reiff AO; Samuels J; Wright DA; Kastner DL; Lovell DJ Ann Intern Med; 2012 Oct; 157(8):533-41. PubMed ID: 23070486 [TBL] [Abstract][Full Text] [Related]
7. Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam. Hageman IMG; Visser H; Veenstra J; Baas F; Siegert CEH Neth J Med; 2019 Jun; 77(5):177-182. PubMed ID: 31264586 [TBL] [Abstract][Full Text] [Related]
8. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever? Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601 [TBL] [Abstract][Full Text] [Related]
9. Non-response to colchicine in familial Mediterranean fever should be identified accurately. Melikoglu MA; Senel K Int J Rheum Dis; 2017 Dec; 20(12):2118-2121. PubMed ID: 24702830 [TBL] [Abstract][Full Text] [Related]
10. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever. Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial. Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222 [TBL] [Abstract][Full Text] [Related]
12. Atypical Familial Mediterranean Fever Presenting with Recurrent Upper Back Pain: A Case Report. Matsumoto H; Saito K; Sumichika Y; Yoshida S; Temmoku J; Fujita Y; Matsuoka N; Asano T; Sato S; Migita K Tohoku J Exp Med; 2023 Jun; 260(2):165-169. PubMed ID: 37045785 [TBL] [Abstract][Full Text] [Related]
13. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience. Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310 [TBL] [Abstract][Full Text] [Related]
14. Can colchicine response be predicted in familial Mediterranean fever patients? Özçakar ZB; Elhan AH; Yalçınkaya F Rheumatology (Oxford); 2014 Oct; 53(10):1767-72. PubMed ID: 24764265 [TBL] [Abstract][Full Text] [Related]
15. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment. Karabulut Y; Gezer HH; Duruöz MT Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430 [TBL] [Abstract][Full Text] [Related]
16. Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study. Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Guler AA; Karadeniz H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kalyoncu U; Kasifoglu T; Tufan A Rheumatol Int; 2020 Jan; 40(1):41-48. PubMed ID: 31392498 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF]. Cetin GY; Balkarli A; Öksüz AN; Kimyon G; Pehlivan Y; Orhan O; Kisacik B; Cobankara V; Sayarlioglu H; Onat AM; Sayarlioglu M Rev Bras Reumatol; 2014; 54(5):356-9. PubMed ID: 25627298 [TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever. Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763 [TBL] [Abstract][Full Text] [Related]
19. Late-onset familial Mediterranean fever in Japan. Kishida D; Yazaki M; Nakamura A; Tsuchiya-Suzuki A; Shimojima Y; Sekijima Y Mod Rheumatol; 2020 May; 30(3):564-567. PubMed ID: 31116049 [No Abstract] [Full Text] [Related]